Technologies

​ SHANGHAI, May 1, 2024 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI) (“Xiao-I” or the “Company”), a leading artificial intelligence company, is proud to announce the forthcoming launch of its innovative product, DIF (Daily Invest Focus), in… Read More »Xiao-I Corporation Announce the significant progress in the new product DIF (Daily Invest Focus), Empowering Investors with Advanced Market Insights

World of Dypians is proud to be part of the 7 projects within Chapter 2 of the Airdrop Alliance Program. Tortola, BVI, May 01, 2024 (GLOBE NEWSWIRE) — World of Dypians (WOD) – an immersive, revolutionary… Read More »World of Dypians Offers Up to 1M $WOD and $225,000 in Premium Subscriptions via the BNB Chain Airdrop Alliance Program

​ LOS ANGELES, May 1, 2024 /PRNewswire/ — As Mother’s Day approaches, Waterdrop, a pioneer in the field of water filtration technology, is pleased to make gift giving a little easier with discounted offerings on… Read More »Celebrate Mother’s Day with Healthy and Practical Gifts from Waterdrop

​ HANOI, Vietnam, April 28, 2024 /PRNewswire/ — 25 April 2024, Evermos, a connected commerce platform that provides distribution networks and integrated commerce services, is proud to announce its achievement in achieving a Gold position… Read More »Evermos Wins Gold Position from The Global CSR & ESG Summit and Awards 2024™ in the Women’s Empowerment Category

​ HONG KONG, May 1, 2024 /PRNewswire/ — The inaugural season of Cards Ahoy’s (CA) leaderboard ended on April 17, 2024, marking not just the conclusion of the season but the onset of a remarkable… Read More »Cards Ahoy’s Player “Werewolf” Wins $500,000 CAC: Lucky Jackpot Shines on Manila Streets

​ Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 OXFORD, England, May 1, 2024 /PRNewswire/ — Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery… Read More »Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers